These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1152612)

  • 1. Morphine tolerance and naloxone receptor binding.
    Harris J; Kazmierowski DT
    Life Sci; 1975 Jun; 16(12):1831-6. PubMed ID: 1152612
    [No Abstract]   [Full Text] [Related]  

  • 2. Narcotic receptor sites in morphine-dependent rats.
    Klee WA; Streaty RA
    Nature; 1974 Mar; 248(5443):61-3. PubMed ID: 4131940
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced affinity of opiate receptors for naloxone in striatal slices of morphine-dependent mice.
    Kitano T; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):341-51. PubMed ID: 199923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
    McGilliard KL; Takemori AE
    J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to morphine in the rat: its prevention by naloxone.
    Mushlin BE; Cochin J
    Life Sci; 1976 Apr; 18(8):797-801. PubMed ID: 1271950
    [No Abstract]   [Full Text] [Related]  

  • 6. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
    Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
    J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of narcotic antagonists with receptor sites.
    Goldstein A
    Adv Biochem Psychopharmacol; 1973; 8(0):471-81. PubMed ID: 4212101
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultra-low dose naloxone upregulates interleukin-10 expression and suppresses neuroinflammation in morphine-tolerant rat spinal cords.
    Lin SL; Tsai RY; Tai YH; Cherng CH; Wu CT; Yeh CC; Wong CS
    Behav Brain Res; 2010 Feb; 207(1):30-6. PubMed ID: 19799935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of morphine-induced analgesia and tolerance in mice by MK-801.
    Lutfy K; Hurlbut DE; Weber E
    Brain Res; 1993 Jul; 616(1-2):83-8. PubMed ID: 8358631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the efficacy of naloxone induced by stress, cyclic adenosine monophosphate, and morphine tolerance.
    Harris RA; Loh HH; Way EL
    Eur J Pharmacol; 1976 Sep; 39(1):1-10. PubMed ID: 183962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents.
    Höllt V; Dum J; Bläsig J; Schubert P; Herz A
    Life Sci; 1975 Jun; 16(12):1823-8. PubMed ID: 1171344
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
    Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
    Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol binding to an opiate receptor site.
    Clay GA; Brougham LR
    Biochem Pharmacol; 1975 Jul; 24(13-14):1363-7. PubMed ID: 1148026
    [No Abstract]   [Full Text] [Related]  

  • 14. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comprehensive study of the neurochemical and immune mechanisms of morphine tolerance: the effects of naloxone].
    Litvinova SV; Shul'govskiĭ VV; Gruden' MA; Panchenko LF; Terebilina NN; Aristova VV; Kaliuzhnyĭ AL
    Patol Fiziol Eksp Ter; 2000; (1):6-9. PubMed ID: 10741178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.
    Yano I; Takemori AE
    Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):721-34. PubMed ID: 16322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cholinergic compounds on the development of morphine tolerance, dependence and increased naloxone potency in mice.
    Wong CL; Bentley GA
    Eur J Pharmacol; 1980 Jan; 61(2):99-109. PubMed ID: 7188753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry of drug dependence.
    Takemori AE
    Annu Rev Biochem; 1974; 43(0):15-33. PubMed ID: 4211836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.